Published on FiercePharma (http://www.fiercepharma.com)

Artes Medical - Worst Pharma Stocks of 2007

By tracy
Created Feb 25 2008 - 3:12pm

Company: Artes Medical [1]
Starting stock price: $8.33
Ending stock price: $2.27
Percent Change: -72.75%

Details: Artes Medical develops and markets injectable products for cosmetic use by dermatologists and plastic surgeons. Its first product, ArteFill, won FDA approval in October 2006 and started shipping in 2007. It competes with collagen injections and Botox.

Previous: Altus Pharmaceuticals [2]Index [3]Next: Vanda Pharmaceuticals [4]
Source URL: http://www.fiercepharma.com/special-reports/artes-medical-worst-pharma-stocks-2007

Links:
[1] http://www.artesmedical.com/
[2] http://www.fiercepharma.com/special-reports/altus-pharmaceuticals-worst-pharma-stocks-2007
[3] http://www.fiercepharma.com/special-reports/worst-pharma-stocks-2007
[4] http://www.fiercepharma.com/special-reports/vanda-pharmaceuticals-worst-pharma-stocks-2007